Bone targeted therapies for the prevention of skeletal morbidity in men with prostate

Bone targeted therapies for the prevention of skeletal morbidity in men with prostate

Men with prostate cancer suffer substantially from bone-related complications. Androgen deprivation therapy itself is a cause of loss of bone mineral density and is associated with an increased incidence of osteoporotic fractures. In advanced disease, bone is by far the most common site of metastasi...

Full description

Bibliographic Details
Main Author: Philip J Saylor
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-06-01
Series:Asian Journal of Andrology
Subjects:
denosumab; osteoporosis; osteopenia; osteoclast; RANK (receptor activator of nuclear factor-kappa B); skeletal-related events
Online Access:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2014;volume=16;issue=3;spage=341;epage=347;aulast=Saylor

Similar Items

Similar Items